The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study
Tobias Heigl,Janne Kaes,Celine Aelbrecht,Jef Serré,Yoshito Yamada,Vincent Geudens,Anke Van Herck,Arno Vanstapel,Annelore Sacreas,Sofie Ordies,Anna Frick,Berta Saez Gimenez,Jan Van Slambrouck,Hanne Beeckmans,Nilüfer A. Acet Oztürk,Michaela Orlitova,Annemie Vaneylen,Sandra Claes,Dominique Schols,Greetje Vande Velde,Jonas Schupp,Naftali Kaminski,Markus Boesch,Hannelie Korf,Schalk van der Merwe,Lieven Dupont,Jeroen Vanoirbeek,Laurent Godinas,Dirk E. Van Raemdonck,Wim Janssens,Ghislaine Gayan-Ramirez,Laurens J. Ceulemans,John E. McDonough,Erik K. Verbeken,Robin Vos,Bart M. Vanaudenaerde
DOI: https://doi.org/10.3389/fimmu.2024.1369536
IF: 7.3
2024-04-26
Frontiers in Immunology
Abstract:Introduction: Chronic rejection is a major complication post-transplantation. Within lung transplantation, chronic rejection was considered as airway centred. Chronic Lung Allograft Dysfunction (CLAD), defined to cover all late chronic complications, makes it more difficult to understand chronic rejection from an immunological perspective. This study investigated the true nature, timing and location of chronic rejection as a whole, within mouse lung transplantation. Methods: 40 mice underwent an orthotopic left lung transplantation, were sacrificed at day 70 and evaluated by histology and in vivo μCT. For timing and location of rejection, extra grafts were sacrificed at day 7, 35, 56 and investigated by ex vivo μCT or single cell RNA (scRNA) profiling. Results: Chronic rejection originated as innate inflammation around small arteries evolving toward adaptive organization with subsequent end-arterial fibrosis and obliterans. Subsequently, venous and pleural infiltration appeared, followed by airway related bronchiolar folding and rarely bronchiolitis obliterans was observed. Ex vivo μCT and scRNA profiling validated the time, location and sequence of events with endothelial destruction and activation as primary onset. Conclusion: Against the current belief, chronic rejection in lung transplantation may start as an arterial response, followed by responses in venules, pleura, and, only in the late stage, bronchioles, as may be seen in some but not all patients with CLAD.
immunology